Navigation

Investiment.io
Financial analysis platform

Colgate-Palmolive Company

CL • NYSE

$100.99
ā–²1.32 (1.32%)• REGULAR

Colgate-Palmolive Company

$100.99
ā–²1.3%
šŸ“ŠSummaryšŸ“‹SEC FilingsšŸ‘„Insider Trading
šŸ“„

CL Q2 2020 Earnings Call

July 31, 2020 at 12:00 AM

Company
CL
Quarter
Q2 2020
Date
July 31, 2020 at 12:00 AM
Speakers
2
Word Count
~5,666

Transcript Content

Operator
And we will take our first question from Dara Mohsenian from Morgan Stanley. Please go ahead.
Speaker
Hi, guys. Hope all is well. The pricing number really accelerated in the quarter to a 3.5% level, which is the best we’ve seen in recent history. Was that more related to sustainable price increases or the RGM efforts that you guys mentioned that have been put in place, particularly in emerging markets, which look like it drove the corporate pricing? Were there any variances specific to the quarter such as promotional spending? And how sustainable are the drivers behind this pricing shift as you look forward? Perhaps you could also discuss demand elasticity in emerging markets with regard to that pricing. Thanks. Noel Wallace (CEO): Yes. Thanks, Dara. As we were coming out of the first quarter, we discussed the significant headwinds we faced regarding foreign exchange, particularly in some emerging markets. As you've likely seen over the years, our teams on the ground have sought to recover the transactional impact of foreign exchange very quickly and quickly apply that pricing into the P&L. You saw that manifest itself through the pricing across the company, largely driven by emerging markets where we experienced the most significant foreign exchange headwinds. Therefore, I am really pleased that our teams were able to get in front of this in the quarter. The strength that we've seen gives us the capability to use that pricing in the P&L going forward, but we will have to invest in the business in the back half of the year. Additionally, there was some pullback in promotions during the quarter. We have been very disciplined with our marketing spend because foot traffic has decreased in certain regions due to lockdowns across markets. We naturally held back with discipline to ensure we can allocate that money to promotional slots in the back half of the year to boost the volume we're looking for later. Thus, we believe the pricing is sustainable. Our early implementation has provided us with the best ability to maintain control moving forward, and we plan to spend strategically in the back half. We feel comfortable with managing some of the foreign exchange impacts we’ve seen.
Operator
And our next question will come from Wendy Nicholson with Citi. Please go ahead.
Speaker
Hi, good morning. Could you talk a little bit more about gross margin? I know you called that out as a specific area of focus in the second quarter. But I am trying to understand the extent of improvement—did it come from reduction in promotional spending, or was it more about structural funding to growth cost savings that we should view as being sustainable versus short-term crisis management type benefits? Thanks. Noel Wallace (CEO): Sure. Well, we obviously saw significant transactions moving through, and despite that, we were able to recover that with strong pricing in the quarter. We experienced elevated foreign exchange headwinds coming out of the first quarter, which carried on as we entered April. This allowed us to take the pricing early in the quarter and capture the full benefit as we progressed. Additionally, our funding growth and productivity efforts have been very strong. As we stepped back, we recognized some complexities associated with disruptions we've faced in the supply chain, along with some portfolio changes we've made. The leverage that we are witnessing come through the P&L has contributed to greater efficiency, subsequently improving our gross margin metrics. Overall, we felt positive regarding our gross profit performance. The early pricing in the quarter aided us, as did funding and productivity measures throughout the quarter. However, we also pulled back on some promotional spending, as we didn't see the expected return on investment given the current downturn in foot traffic. As we observe foot traffic returning in the second half of the year, we intend to remain competitive and continue to drive volume.
Operator
And our next question will come from Andrea Teixeira from JPMorgan. Please go ahead.
Speaker
Yes. Hi, I think you and hope all is well. Noel, if you can comment a bit on the supply chain in terms of your capacity increasing over the quarter? And then discussing stock outages on shelves, if you can provide a global perspective on that. Thank you. Noel Wallace (CEO): Sure. In general, as I mentioned earlier, the supply chain has performed extremely well. The demand in some of our categories has significantly surged, reaching levels we’ve never seen. This forced our teams very early on to simplify and optimize our portfolios to maximize throughput in our factories. This change has been well received by our trade partners as it has improved our case bill numbers with them. That being said, we still have categories where we are not meeting demand. For instance, the demand for liquid hand soap exceeds our current capacity. We brought on capacity through contractors to mitigate that, and we did see some of the effects on the U.S. margin line. However, we’re working to fulfill the requirements of our retail partners. We are exploring how to increase capital investment in certain facilities as we anticipate ongoing elevated demand for some of these categories. We’ve also implemented innovative packaging that has enabled us to repurpose unused production lines for specific categories, allowing us to better meet current demands. Overall, we are successfully managing almost all of our demand, except for a few categories like liquid hand soap and dish soap where we are still working to catch up. We expect to see improvements in this aspect in the back half of the year as we increase capacity and enhance efficiency with contractors.
Operator
And our next question will come from Olivia Tong with Bank of America. Please go ahead.
Speaker
Thanks. Good morning. Hope everyone is well. I have two questions; first, could you walk through growth across categories instead of divisions and provide some insights into category-specific numbers if possible? Additionally, I'm interested in emerging market trends, particularly in Latin America given the current recession. While the volume numbers have fluctuated, pricing has increased dramatically. Can you comment on the underlying growth within those categories and your strategy to manage a potential downturn macroscopically? Thank you. Noel Wallace (CEO): Sure. In aggregate, our broad-based categories are up versus the same period last year, driven largely by the significant demand for health and hygiene products in our competitive landscape. We’ve observed fluctuations in category performances throughout the year. Some categories, such as oral care, experienced substantial spikes due to pantry loading in the first quarter and those effects have extended through the second quarter. However, overall, most categories have displayed growth. We’ve particularly seen heightened demand in liquid hand soap, bar soap, cleaners, and dish soap. This demand is likely to continue as consumer behavior shifts regarding work and home routines, which should also benefit our categories in the back half of the year. Concerning Latin America specifically, we are well-prepared to withstand this recession, having navigated several before. Our strategy allows us to be proactive with pricing to maximize flexibility in tougher environments. Our product portfolio is highly competitive, with ongoing innovation across various price points. For instance, in Latin America, we derive 50% of our toothpaste business from mid-priced products and 25% from value. There are significant opportunities for enhancing our premium offerings as consumers contend with recessionary pressures. As previously highlighted, we strive to innovate continuously behind our core businesses, and we have major core innovations planned for the upcoming 12 months. Thus, we feel we are well-equipped to handle the recession as it may unfold.
Operator
And next we will hear from Jason English with Goldman Sachs. Please go ahead.
Speaker
Hey, good morning, folks. Congratulations on your strong results. Noel Wallace (CEO): Thanks.
Speaker
Noel, I think you mentioned in your response to the previous question that you’ve seen improvements in toothpaste or oral care in Latin America throughout the quarter. Could you provide some quantification or specificity on overall performance in Latin America month-on-month and how it's tracking as you exit the quarter? Additionally, could you give similar figures for your developing markets overall? Noel Wallace (CEO): Okay. I’m not sure I fully understood the first part of your question regarding volume versus pricing for LATAM. Let me discuss LATAM as a whole for the quarter, which performed well despite grappling with significant challenges and disruptions. By disruptions, I'm referring to the shutdown of numerous smaller trading partners in various countries and extended closures of major department stores, leading to declines in traffic. Consequently, while our shares in categories performed well across the board, volume inevitably dropped in response to these challenges. Pricing increased significantly in the quarter, and this was partly a consequence of navigating disruptions in the marketplace related to retail environments being closed for prolonged periods. As we saw some recovery in foot traffic towards the end of the quarter, we expect that improvement to continue in the latter half of the year. That said, I would caution that infection rates remain a concern, particularly in significant LATAM markets such as Brazil, which creates uncertainty about consumer mobility and access to stores. Overall, LATAM shares have performed well, although we did experience some volume softness due to the challenges mentioned earlier. Strong pricing adjustments have been in place, and we aim to make substantial investments in LATAM during the second half of the year through advertising to support innovation.
Operator
And our next question will come from Steve Powers with Deutsche Bank. Please go ahead.
Speaker
Hey. Thanks. Good morning. If I step back and observe the composition of your P&L for the first half of the year, it looks quite healthy despite the volatility. Your gross margins are solidly above 60%, while advertising and promotion expenses are running at around 11.5% of sales. Can you discuss the key enablers behind this? And is there any significant reason to believe that this composition will meaningfully change in the back half of the year? Noel Wallace (CEO): Sure. Once again, we must return to the strategy we’ve been pursuing, which emphasizes foundational innovation, a significant element of our portfolio. As we concentrate on core innovation, we also make strategic pricing decisions. This approach is clearly reflected in our gross margin improvement metrics. Additionally, we have effectively managed to get ahead of foreign exchange problems, particularly in key markets, which has thus contributed directly to the observed gross margin expansion. Moreover, we have seen substantial growth in e-commerce and other untracked channels, consistent with our 18-month strategy. The COVID-19 situation has acted as a catalyst for accelerating our strategy around adjacencies, and we've quickly rolled out those products into the market as consumer behaviors continue to shift. By incorporating more health and hygiene-oriented products into our portfolio, we’re looking to stabilize our organic growth moving forward. However, we also anticipate that competition may increase in the back half of the year as more markets gradually reopen. With that in mind, we have strategically pivoted to introduce pricing efforts into the market to better prepare ourselves for potential changes.
Operator
And our next question will come from Lauren Lieberman with Barclays. Please go ahead.
Speaker
Great. Thanks. Good morning. I wanted to discuss cost beyond what you mentioned regarding productivity. I believe last year you spoke extensively about executing with agility, particularly on the revenue side. As you've navigated the first few months of this crisis, are there operational structures that you've uncovered that present further efficiency opportunities within the cost side of your P&L? Besides travel-related expenses, can you point to areas ripe for improvement in your overall cost structure beyond T&E? Thank you. Noel Wallace (CEO): Sure. Thanks, Lauren. We have indeed been discussing productivity beyond the successes we've experienced with funding growth over the years. While we've been examining all line items quarterly, we've also come to understand how to pursue a different approach to productivity in a pandemic context, utilizing efficiencies throughout our income statement structure. Specifically, a couple of areas stand out. Our travel expenses, as expected, have dropped since we are operating in 200 countries. The digital transformation we’ve undergone has allowed us to shift towards a virtual workforce and reduced travel costs. Additionally, the skills we've learned in utilizing digital tools provide us with significant savings moving forward. Our teams have become adept at leveraging virtual technologies to address operations in our plants more efficiently rather than relying on traditional travel methods. Furthermore, we have consolidated our portfolio and streamlined our operations, which has included cutting certain SKUs that were less profitable. Although this has facilitated production efficiency, we recognize the need to evaluate how we can optimize our portfolio in the long term. Also, we have gained insights on managing within an omnichannel environment more effectively, mapping the consumer journey, and adjusting our strategy accordingly. Last but not least, we are scrutinizing the overall cost structures in our offices and teams globally to ensure optimal effectiveness as we consider the long-term outlook.
Operator
And our next question will come from Kevin Grundy with Jefferies. Please go ahead.
Speaker
Great. Thanks. Good morning everyone, and congratulations on the solid results. Noel, I wanted to follow up on Jason English's line of thinking around guidance, specifically concerning Latin America. The decision not to reinstitute guidance stands out, especially considering that we've seen competitors reinstitute practices. John presented various directional guidance points, and the tone of this call appears positive. How much deliberation went into this decision? What insights can you share about July's performance specifically? Moreover, is the message that, while the overall outlook is uncertain, this is more about prudence in light of the pandemic rather than indicative of sequential weaknesses that investors should be concerned about? Noel Wallace (CEO): Yes. Thanks, Kevin. Regarding July, I want to steer clear of offering precedents, as I know how sensitive the absence of guidance can be for external expectations. However, I will indicate that July has started as planned. Concerning guidance, I have little additional information. The unknowns can be quite formidable. As you may have noticed, compared to the situation we faced during the first quarter, the virus has spread further. We’ve experienced increases in case counts in key markets, leading to ongoing disruptions and temporary closures at retail locations. Furthermore, changes in consumer behavior have resulted in significant weekly volatility across product categories, complicating accurate predictions. That backdrop explains why we maintain our current position on guidance—we want to ensure we offer guidance only when there's sufficient confidence in future outcomes. Moving forward, we hope to revisit guidance as we gather more information and gain greater confidence in our projections.
Operator
And our final question will come from Rob Ottenstein with Evercore. Please go ahead.
Speaker
Great. Thank you very much. I am wondering if we can touch on some of the pre-COVID priorities that you had to get a sense of your progress amidst the ongoing changes, specifically on your premiumization initiatives outside the U.S., your competition against local natural brands in China and India, and the expansion of Elmex and Meridol. Could you provide a rundown on these initiatives and confirm whether they remain relevant? Noel Wallace (CEO): Yes. Thanks, Rob. I want to reiterate that we believe our strategy remains well-suited for the behaviors and dynamics we are currently observing in the marketplace. We must continue to reinforce our commitment to core innovation—this is a big part of our portfolio. As we persist with our core inventory and adjacencies, we’re refining how we penetrate rapidly growing segments—we’re pursuing floor cleaner innovations that integrate hygiene and antibacterial features. We’ve also seen the digital commerce business grow consistently and that trajectory can be attributed to successful execution within our Hill’s brand. We've been ramping up internal capabilities as well as recruiting outside talent, which has given us fresh perspectives. It’s imperative to note that our strategy is working. We’ve achieved qualitative growth and innovation, and the agility lessons learned through the crisis can lead to expedited launches moving forward. We’ve defined several objectives around premiumization, particularly within the toothpaste business where 50% of our offerings are mid-priced and 25% fall into the value sector. Accelerating our share of premium offerings continues to be vital. Our recent introduction of Optic White Renewal is a notable example, as is our pursuit of surging demand for ultra-premium products—a segment we have historically ignored. Our insights indicate that premium, value-oriented products continue to resonate with consumers, especially during recessionary periods. Therefore, we intend to match this demand with effective marketing and innovation strategies. As for the naturals movement, we’re optimistic about our strategy with Tom’s of Maine; they have exciting future opportunities. Additionally, Hello is expanding rapidly within U.S. markets and we anticipate the long-term appeal of purpose-driven brands, which is essential for sustainable growth. In regards to Elmex, we’re being selective and strategically positioning it within high-pharmacy environments, making notable progress. Brazil has been an early success in this regard, facilitated by our emphasis on pharmacy channels, and this patient approach contrasts with short-term volume aspirations. We’re focused on establishing a robust therapeutic business there, which will take time but can yield significant returns. Overall, I believe this quarter was of high quality, but we also acknowledge that we have more work ahead and many challenges still await. I want to extend my gratitude to our 36,000 Colgate employees around the world who have remained exceptionally resilient and dedicated to executing our strategy and building new capabilities across the organization. The success we experienced this quarter can be attributed to their efforts. Thank you everyone, and we look forward to speaking with you soon.
Operator
And this concludes today's conference. Thank you for your participation, and you may now disconnect.